Z-1803-2013 Class II Terminated
FDA device recall Z-1803-2013 was initiated by Becton Dickinson & Co. on Jun 6, 2013 and is designated Class II. Reason for recall: Microbiological identification media may exhibit reduced levels of Vancomycin. The recall status is terminated (terminated Sep 3, 2013). Affected quantity: 92 cartons.
Recall Details
- Product Type
- Devices
- Report Date
- Jul 31, 2013
- Initiation Date
- Jun 6, 2013
- Termination Date
- Sep 3, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 92 cartons
Product Description
BBL Brucella Laked Blood Agar with Kanamycin and Vancomycin (KV), Catalog # 297840, packaged in cartons of 20 plates, labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Brucella Laked Blood with KV is used for the selective isolation of fastidious and slow growing, obligately anaerobic bacteria from the same specimen.
Reason for Recall
Microbiological identification media may exhibit reduced levels of Vancomycin.
Distribution Pattern
Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.
Code Information
Lot 3078280 Exp 6/27/13
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1803-2013
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026